151. KRAS Engages AGO2 to Enhance Cellular Transformation
- Author
-
Shankar, Sunita, Pitchiaya, Sethuramasundaram, Malik, Rohit, Kothari, Vishal, Hosono, Yasuyuki, Yocum, Anastasia K, Gundlapalli, Harika, White, Yasmine, Firestone, Ari, Cao, Xuhong, Dhanasekaran, Saravana M, Stuckey, Jeanne A, Bollag, Gideon, Shannon, Kevin, Walter, Nils G, Kumar-Sinha, Chandan, and Chinnaiyan, Arul M
- Subjects
Biochemistry and Cell Biology ,Biological Sciences ,Cancer ,Aetiology ,2.1 Biological and endogenous factors ,Animals ,Argonaute Proteins ,Base Sequence ,Carboxypeptidases ,Cell Transformation ,Neoplastic ,Endoplasmic Reticulum ,Gene Expression Regulation ,Neoplastic ,Gene Silencing ,Humans ,Mice ,MicroRNAs ,Molecular Sequence Data ,Mutation ,NIH 3T3 Cells ,Phosphatidylinositol 3-Kinases ,Protein Binding ,Proto-Oncogene Proteins p21(ras) ,RNA ,Small Interfering ,Transgenes ,Argonaute 2 ,EIF2C2 ,KRAS ,RNA silencing ,cancer ,Medical Physiology ,Biological sciences - Abstract
Oncogenic mutations in RAS provide a compelling yet intractable therapeutic target. Using co-immunoprecipitation mass spectrometry, we uncovered an interaction between RAS and Argonaute 2 (AGO2). Endogenously, RAS and AGO2 co-sediment and co-localize in the endoplasmic reticulum. The AGO2 N-terminal domain directly binds the Switch II region of KRAS, agnostic of nucleotide (GDP/GTP) binding. Functionally, AGO2 knockdown attenuates cell proliferation in mutant KRAS-dependent cells and AGO2 overexpression enhances KRAS(G12V)-mediated transformation. Using AGO2-/- cells, we demonstrate that the RAS-AGO2 interaction is required for maximal mutant KRAS expression and cellular transformation. Mechanistically, oncogenic KRAS attenuates AGO2-mediated gene silencing. Overall, the functional interaction with AGO2 extends KRAS function beyond its canonical role in signaling.
- Published
- 2016